McFarlane Neil F. insider trades
McFarlane Neil F. has filed 13 Form 4s with the SEC that we hold, for Zevra Therapeutics, INC. (ZVRA) (President and CEO, Director), Collegium Pharmaceutical, INC (COLL) (Director) and ADMS (Chief Executive Officer, Director). Across all of them we count 0 purchases worth $0 and 5 sales worth $1.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($978.8K). The largest single trade was a sale of 91,000 shares of Zevra Therapeutics, INC. worth $853.6K, dated 2026-02-02. The first filing on our record is dated 2021-11-24 and the latest 2026-02-10.
Zevra Therapeutics, INC. (ZVRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-02-13 | S, sale reported on Form 4 | 61,273 | $481.6K | 2025-02-14 |
| 2025-02-14 | S, sale reported on Form 4 | 30,544 | $245.9K | 2025-02-14 |
| 2025-10-10 | S, sale reported on Form 4 | 19,500 | $211.0K | 2025-10-10 |
| 2026-02-02 | S, sale reported on Form 4 | 91,000 | $853.6K | 2026-02-02 |
| 2026-02-09 | S, sale reported on Form 4 | 14,625 | $125.2K | 2026-02-10 |
Collegium Pharmaceutical, INC (COLL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
ADMS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1681098) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms